PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportshistoplasmosis
MeSH D006660 - histoplasmosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D009181:Mycoses
144 Companies
35 Drugs
$
Success rate
D006660: 
Histoplasmosis
61 Companies
6 Drugs
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaAmphotericin b Amphotericin B  1995-03-31   
Fluconazole Fluconazole  2004-07-29   
Ketoconazole Ketoconazole  1999-06-15   
PadagisKetoconazole Ketoconazole  2004-01-07   
Taro PharmaceuticalFluconazole Fluconazole  2004-07-29   
Ketoconazole Ketoconazole  1999-06-15   
Ketoconazole Ketozole  2002-12-18   
Glenmark PharmaceuticalsFluconazole Fluconazole  2006-01-25   
MylanKetoconazole Extina  2007-06-12   
Fluconazole Fluconazole  2004-07-29   
Itraconazole Itraconazole  2012-07-20   
Mayne GroupItraconazole Tolsura 2023-07-25 2018-12-11   
XiromedKetoconazole Ketoconazole  2021-05-21   
Johnson & JohnsonKetoconazole Nizoral  1986-11-07   
Itraconazole Sporanox  1992-09-11   
AlmirallKetoconazole Xolegel  2006-07-28   
SandozItraconazole Itraconazole  2004-05-28   
1
2
3
4
5
6
7
>
Clinical Trials
Historical Success Rate
Phase 1
100%
1/1
Phase 2
67%
2/3
Phase 3
89%
8/9
Approved: 6Overall Success rate: 59%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Taro Pharmaceutical
Ketoconazole
Mylan
Fluconazole
Mayne Group
Itraconazole
Johnson & Johnson
Itraconazole,
Ketoconazole
Pfizer
Fluconazole,
Pdt
Dr Reddys Laboratories
Fluconazole
1
2
3
4
5
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use